Article

SARS-CoV-2 mRNA Vaccination Induces an Antigen-Specific T Cell Response Correlating with Plasma Interferon-Gamma in B Cell Depleted Patients

2023-04-27

Abstract excerpt

Objectives: Compare two assays measuring T cellular immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination in patients on anti-CD20 therapy.<br><br>Methods: We performed an observational prospective study of 24 participants with either multiple sclerosis or another autoimmune neurological disorder treated with anti-CD20 infusion therapy who received a SARS-CoV-2 mRNA vaccine, c...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e3cbc0ff-7ad1-52ec-a7fb-1921f2091676
DOI: 10.2139/ssrn.4428557

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 mRNA Vaccination Induces an Antigen-Specific T Cell Response Correlating with Plasma Interferon-Gamma in B Cell Depleted PatientsDOI 10.2139/ssrn.4428557Read

Distinct Patterns of Humoral and Cellular Immune Responses Following SARS-CoV-2 mRNA Vaccination in Patients With Immune-Mediated Neurological Disorders on Anti-CD20 Therapy: A Prospective Cohort StudySemantic proximity Read

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patientsSemantic proximity Read

Cellular and Humoral Responses to SARS-CoV-2 Vaccination in Immunosuppressed PatientsSemantic proximity Read

Discrete Immune Response Signature to SARS-CoV-2 mRNA Vaccination Versus InfectionSemantic proximity Read

mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infectionSemantic proximity Read

mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infectionSemantic proximity Read

Altered cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySemantic proximity Read

Anti-SARS-CoV-2 cellular immunity in 571 vaccinees assessed using an interferon-γ release assaySemantic proximity Read

Evaluation of Humoral and Cellular Immune Responses to the SARS-CoV-2 Vaccine in Patients With Common Variable Immunodeficiency Phenotype and Patient Receiving B-Cell Depletion Therapy.Semantic proximity Read

Characterizing the cellular and molecular variabilities of peripheral immune cells in healthy recipients of BBIBP-CorV inactivated SARS-CoV-2 vaccine by single-cell RNA sequencingSemantic proximity Read

B- and T-cell Specific Responses to Vaccination against SARS-CoV-2 in Anti-CD20 Treated Patients with Relapsing-Remitting or Progressive Form of Multiple Sclerosis Reveal Immunosenescent FeaturesSemantic proximity Read

Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell ImmunitySemantic proximity Read